deltatrials
Completed NA INTERVENTIONAL 1-arm NCT03104907

Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer

Sponsor: Rigshospitalet, Denmark

Updated 8 times since 2017 Last updated: Nov 27, 2018 Started: Mar 22, 2017 Primary completion: Nov 27, 2018 Completion: Nov 27, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Lower Urinary Tract Symptoms and Prostatic Diseases and is currently completed. Rigshospitalet, Denmark leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~May 2017 – ~Jun 2018 · 13 months · monthly snapshotRecruiting~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotRecruiting~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshotActive Not Recruiting~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshotActive Not Recruiting~Dec 2018 – ~Jan 2021 · 25 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Dec 2018 — Jan 2021 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

  5. Sep 2018 — Dec 2018 [monthly]

    Active Not Recruiting NA

Show 3 earlier versions
  1. Jul 2018 — Sep 2018 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  2. Jun 2018 — Jul 2018 [monthly]

    Recruiting NA

  3. May 2017 — Jun 2018 [monthly]

    Recruiting NA

    First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Rigshospitalet, Denmark
Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations